| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 02/23/1999 | US5874573 Cyclic amine derivatives |
| 02/23/1999 | US5874542 Single chain antibodies specific to VEGF receptors |
| 02/23/1999 | US5874540 CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies |
| 02/23/1999 | US5874528 Binding peptides which interact with ligand growth factors of the epidermal growth factor receptor and erbB-2 receptor |
| 02/23/1999 | US5874059 Diagnosing neoplasma wherein cells have increased number of low density lipoprotein receptors |
| 02/23/1999 | US5873904 Silver implantable medical device |
| 02/23/1999 | US5873811 Method for inhibiting restonosis at a vessel wall region |
| 02/23/1999 | CA1340409C Functionally specific antibodies |
| 02/17/1999 | EP0896547A1 Diagnostic composition |
| 02/17/1999 | CN1208353A Contrast media |
| 02/16/1999 | US5871936 Detection and treatment of breast cancer using monoclonal antibodies produced by hybridoma formed by fusing mouse lymphocytes and myeloma cells; solid tumor shrinkage |
| 02/16/1999 | US5871711 Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses |
| 02/16/1999 | US5871709 Tetraazacyclododecane compounds substituted with alkyl carboxy compounds for cardiovascular disorders and brain tumors |
| 02/16/1999 | US5871708 Radioactive patch/film and process for preparation thereof |
| 02/16/1999 | US5871437 Radioactive stent for treating blood vessels to prevent restenosis |
| 02/16/1999 | US5871436 Radiation therapy method and device |
| 02/16/1999 | CA2066192C Radiation synovectomy compositions |
| 02/16/1999 | CA2000913C Family of high affinity antibodies for cancer treatment |
| 02/11/1999 | WO1999006042A1 Caspases and apoptosis |
| 02/11/1999 | CA2298668A1 Caspases and apoptosis |
| 02/10/1999 | CN1207811A Method of diagnosing and treating epithelioma |
| 02/09/1999 | US5869651 Hydrazide derivatives of polyamides and their medical use as chelating agents |
| 02/09/1999 | US5869618 For diagnosis of cancers related to erbb-2 oncogene expression |
| 02/09/1999 | US5869616 Imaging agent composed of n-terminal amino acid sequence of fibronectin and label; for noninvasive, accurate diagnosis of a thrombus or atherosclerotic plaque |
| 02/09/1999 | US5869045 Polypeptide comprising antigen-binding region of monoclonal antibody produced by specified hybridoma |
| 02/09/1999 | US5868757 For use with an imaging device |
| 02/04/1999 | WO1999005171A1 NOVEL ESTROGEN RECEPTOR β AND ISOFORMS |
| 02/04/1999 | WO1999005170A1 NOVEL ESTROGEN β RECEPTOR AND ISOFORMS |
| 02/04/1999 | WO1999004827A1 Method for detection of fibrin clots |
| 02/04/1999 | WO1999004826A1 Method for detection of fibrin clots |
| 02/04/1999 | WO1998051337A3 Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors |
| 02/04/1999 | DE19729013A1 Oligomere, perfluoralkylhaltige Verbindungen, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik Oligomers, perfluoroalkyl-containing compounds, processes for their preparation and their use in NMR diagnosis |
| 02/04/1999 | CA2298053A1 Novel estrogen receptor .beta. and isoforms |
| 02/04/1999 | CA2297907A1 Human estrogen receptor beta |
| 02/03/1999 | EP0894012A2 Radioactivity local delivery system |
| 02/03/1999 | EP0724601A4 S 3n chelating compounds for the radiolabeling of ligands, anti-ligands or other proteins |
| 02/03/1999 | EP0510186B1 Therapeutic uses of melanin |
| 02/02/1999 | US5866544 Peptide-chelator conjugates |
| 02/02/1999 | US5866127 Vascular permeability factor targeted compounds |
| 02/02/1999 | US5866097 Technetium-99m labeled peptides for imaging |
| 01/28/1999 | WO1998046275A3 Blood-pool carrier for lipophilic imaging agents |
| 01/26/1999 | US5864038 Fluorine or iodine labels for imaging |
| 01/26/1999 | US5863990 Biodegradable polyacetal polymers and methods for their formation and use |
| 01/26/1999 | US5863739 Assay and kit for the detection of α platelet derived growth factor receptor |
| 01/26/1999 | US5863538 Compositions for targeting the vasculature of solid tumors |
| 01/26/1999 | US5863517 Process for the preparation of an organ-specific substance labeled with technetium-99m |
| 01/21/1999 | WO1999002545A2 Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 01/21/1999 | WO1999002526A1 Tropane analogs and methods for inhibition of monoamine transport |
| 01/21/1999 | WO1999002505A1 Il-5 inhibiting 6-azauracil derivatives |
| 01/21/1999 | WO1999002504A1 6-azauracil derivatives as il-5 inhibitors |
| 01/21/1999 | WO1999002195A2 Coronary stent with a radioactive, radiopaque coating |
| 01/21/1999 | WO1999002194A1 Methods and systems for preparing and sealing radiation delivery structures |
| 01/21/1999 | WO1999002154A1 Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias |
| 01/21/1999 | WO1998031389A3 Fibronectin binding protein compositions, antibodies thereto, and methods of use |
| 01/21/1999 | CA2297187A1 Tropane analogs and methods for inhibition of monoamine transport |
| 01/21/1999 | CA2295375A1 Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 01/21/1999 | CA2294533A1 6-azauracil derivatives as il-5 inhibitors |
| 01/21/1999 | CA2294145A1 Il-5 inhibiting 6-azauracil derivatives |
| 01/20/1999 | EP0850072A4 A method for preparing radiolabeled peptides |
| 01/19/1999 | US5861159 Controlled release of pharmaceutically active substances for immunotherapy |
| 01/19/1999 | US5861156 Methods of delivering agents to target cells |
| 01/19/1999 | US5861139 Method and composition for labeling proteins, peptides and amino acids, including antibodies, with a variety of metals ions (tin), including radioisotopes |
| 01/19/1999 | CA2165294C An iodinated neuroprobe for mapping monoamine reuptake sites |
| 01/19/1999 | CA2003326C Bone marrow suppressing agents |
| 01/19/1999 | CA1340327C Mhc-mediated toxic conjugates useful in ameliorating autoimmunity |
| 01/14/1999 | WO1999001161A1 Perfluoroalkylated oligomer compounds, process for preparing the same and their use in nmr diagnosis |
| 01/14/1999 | WO1998042729A3 Steroid sulfamates, method for the production and use thereof |
| 01/13/1999 | EP0889739A1 Measurement of gastric emptying |
| 01/12/1999 | US5858688 Gro genes, proteins, and uses thereof |
| 01/12/1999 | US5858327 Conjugation to targetting and labelling biomolecules like proteins, peptides and antibodies; contrast agents for tomagraphy diagnosis |
| 01/12/1999 | CA1340312C Methods for improved targeting of antibody, antibody fragments, hormonesand other targeting agents and conjugates thereof |
| 01/07/1999 | WO1999000654A2 Radiolabeled farnesyl-protein transferase inhibitors |
| 01/07/1999 | WO1999000386A1 Dopamine d4 receptor ligands |
| 01/07/1999 | WO1999000150A2 Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor |
| 01/07/1999 | EP0888354A1 Process for producing radiolabelled benzodiazepine receptor agents and composition containing the same |
| 01/07/1999 | EP0888345A1 Sigma-2 receptors as biomarkers of tumor cell proliferation |
| 01/07/1999 | EP0888130A2 New ternary radiopharmaceutical complexes |
| 01/07/1999 | EP0793519A4 X-ray emitting interstitial implants |
| 01/07/1999 | CA2288786A1 Radiolabeled farnesyl-protein transferase inhibitors |
| 01/05/1999 | US5856566 Colored particles; irradiation of crystals |
| 01/05/1999 | US5856515 Electron-deficient porphyrins and processes and intermediates for preparing same |
| 01/05/1999 | US5855867 Radiological imaging |
| 01/05/1999 | US5855866 Constructs designed to have a cytotoxic or otherwise anticellular effect against tumor vasculature |
| 01/05/1999 | CA2005880C Macrocyclic aminophosphonic acid complexes, their preparation formulations and use |
| 12/30/1998 | EP0705105A4 Metal chelates as spacer compounds in biologically active peptides |
| 12/30/1998 | EP0648130B1 Radioiodinated benzovesamicol analogs for cholinergic nerve mapping |
| 12/30/1998 | EP0584273B1 Antibody recognizing endothelial cell ligand for leukocyte cr3 |
| 12/29/1998 | US5854968 Process and apparatus for the production of BI-213 cations |
| 12/29/1998 | US5854204 Aβ peptides that modulate β-amyloid aggregation |
| 12/29/1998 | US5853699 Use of tetra azacycle complexes as x-ray diagnostic agents for the liver and gallbladder |
| 12/29/1998 | US5853696 Substituted 2-carboxyalkyl-3(fluorophenyl)-8-(3-halopropen-2-yl) nortropanes and their use as imaging agents for neurodegenerative disorders |
| 12/29/1998 | US5853695 Method for palliation of pain in human bone cancer using therapeutic tin-117m compositions |
| 12/24/1998 | DE19724223C1 Production of radioactive coated stent, especially at point of use |
| 12/23/1998 | WO1998057668A1 Diagnostic agents and remedies for malignant tumors |
| 12/23/1998 | WO1998057667A1 Methods of photoacoustic imaging |
| 12/23/1998 | WO1998057665A2 The use of mononuclear phagocytes in in vivo imaging of hypoxic/ischaemic tissue |
| 12/23/1998 | EP0885202A1 Polychelants, their complexes with metal ions, their preparation and their uses |
| 12/23/1998 | EP0885017A2 Use of labelled cck-b receptor ligands for the detection and localization of malignant human tumours |
| 12/23/1998 | EP0710246A4 Thrombin receptor radioligands and assays for identifying thrombin receptor antagonists |
| 12/23/1998 | CN1202834A Hollow-tube brachytherapy device |